• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Neuralstem, Inc. (CUR)

    -NYSE MKT
    2.63 Down 0.07(2.59%) 3:59PM EST
    - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.70
    Open:2.72
    Bid:2.61 x 900
    Ask:2.63 x 1500
    1y Target Est:7.00
    Beta:2.37
    Earnings Date:Mar 9 - Mar 13 (Est.)
    Day's Range:2.50 - 2.73
    52wk Range:2.12 - 4.81
    Volume:468,181
    Avg Vol (3m):515,170
    Market Cap:229.75M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CUR

    Comparison

    Symbol% ChgMkt Cap
    CURDown 2.59%229.75M
    GERNUp 3.65%513.29M
    STEMUp 10.86%67.35M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14,152.72
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.23
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback